BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Nautilus Biotech 

1, rue Pierre Fontaine

Evry    91000  France
Phone: 33-0-1-60-87-54-60 Fax: 33-0-1-60-87-54-61


SEARCH JOBS


Industry
Biotechnology






 Company News
Han All Pharmaceutical Co., Ltd. (009420.KS) Acquires Global Rights To Nautilus Biotech's Protein Engineering Technology For Developing Novel Oral And Injectable Therapeutic Proteins 6/29/2009 1:49:11 PM    More...
Nautilus Biotech Receives FDA Approval for Phase 1 Clinical Trial in the USA for Oral Belerofon(R), its Long-Lasting, Interferon-Alpha Drug 5/21/2007 12:07:50 PM    More...
Nautilus Biotech Receives FDA Approval for Phase 1 Clinical Trial in the USA for Oral Belerofon(R), its Long-Lasting, Interferon-Alpha Drug 5/14/2007 11:29:55 AM    More...
Nautilus Biotech Closes EUR8.4 Million ($11.3 Million) Investment Funding 4/30/2007 1:48:36 PM    More...
Nautilus Biotech Begins Phase I Clinical Trial in the USA for Subcutaneous Belerofon(R), its Long-Lasting, Interferon-Alpha Drug 4/2/2007 11:04:51 AM    More...
Nautilus Biotech and Han All Pharmaceutical Co., Ltd. (009420.KS) Announce License Agreement to Develop Three Nautilus Biotech Products in South Korea 3/6/2007 1:15:53 PM    More...
Nautilus Biotech Announces IND Filing for Belerofon®, Its Oral, Long-lasting, Interferon-alpha Drug 3/2/2007 6:17:25 PM    More...
Wyeth (WYE) And Nautilus Biotech Announce Collaboration To Develop Hemophilia Therapies 2/5/2007 9:33:48 AM    More...
Nautilus Biotech And Creabilis Therapeutics Achieve Technical Milestone In Collaboration To Improve HMGB1 Box A For The Treatment Of Rage- And HMGB1-Related Pathologies 11/14/2006 10:41:43 AM    More...
Nautilus Biotech Announces IND Filing For Its Injectable Long-Lasting Interferon-alpha, BELEROFON(R) 10/10/2006 10:57:27 AM    More...
123

//-->